Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calciphylaxis | 38 | 2024 | 130 | 13.050 |
Why?
|
Renal Dialysis | 30 | 2024 | 1796 | 3.910 |
Why?
|
Kidney Failure, Chronic | 36 | 2024 | 2472 | 3.830 |
Why?
|
Renal Insufficiency, Chronic | 22 | 2024 | 2242 | 3.090 |
Why?
|
Thiosulfates | 9 | 2020 | 53 | 2.480 |
Why?
|
Uremia | 5 | 2019 | 201 | 2.080 |
Why?
|
Hyponatremia | 7 | 2023 | 279 | 2.000 |
Why?
|
Nephrology | 5 | 2024 | 263 | 1.410 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1924 | 1.400 |
Why?
|
Hyperparathyroidism, Secondary | 4 | 2019 | 125 | 1.320 |
Why?
|
Olfaction Disorders | 2 | 2022 | 224 | 1.130 |
Why?
|
Skin Diseases | 5 | 2020 | 1094 | 1.060 |
Why?
|
Anemia, Sickle Cell | 5 | 2021 | 1063 | 1.050 |
Why?
|
Vitamin K | 2 | 2019 | 318 | 0.990 |
Why?
|
Leg Ulcer | 2 | 2019 | 71 | 0.910 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 17 | 0.890 |
Why?
|
Sickle Cell Trait | 3 | 2021 | 85 | 0.850 |
Why?
|
Taste Disorders | 1 | 2022 | 38 | 0.790 |
Why?
|
Hip Fractures | 4 | 2019 | 988 | 0.770 |
Why?
|
Hyperphosphatemia | 2 | 2023 | 38 | 0.730 |
Why?
|
Dialysis Solutions | 1 | 2019 | 33 | 0.680 |
Why?
|
Sodium | 3 | 2023 | 1588 | 0.680 |
Why?
|
Parathyroidectomy | 3 | 2019 | 242 | 0.660 |
Why?
|
Vitamin K Deficiency | 1 | 2019 | 24 | 0.640 |
Why?
|
Kidney Diseases | 10 | 2018 | 2091 | 0.620 |
Why?
|
Arterioles | 2 | 2016 | 250 | 0.610 |
Why?
|
Hyperhomocysteinemia | 2 | 2016 | 118 | 0.610 |
Why?
|
Ergocalciferols | 3 | 2015 | 110 | 0.610 |
Why?
|
Atrial Natriuretic Factor | 2 | 2009 | 350 | 0.600 |
Why?
|
Chelating Agents | 3 | 2020 | 387 | 0.590 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2009 | 189 | 0.580 |
Why?
|
Skin | 5 | 2020 | 4484 | 0.570 |
Why?
|
Vitamin B Complex | 2 | 2016 | 299 | 0.560 |
Why?
|
Carboxylic Acids | 1 | 2017 | 90 | 0.540 |
Why?
|
Hypotension | 1 | 2022 | 879 | 0.530 |
Why?
|
Potassium | 1 | 2019 | 1311 | 0.500 |
Why?
|
Folic Acid | 3 | 2016 | 1323 | 0.460 |
Why?
|
Humans | 124 | 2024 | 761596 | 0.460 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.450 |
Why?
|
Hospitalists | 2 | 2008 | 294 | 0.440 |
Why?
|
Randomized Controlled Trials as Topic | 19 | 2020 | 10212 | 0.440 |
Why?
|
Referral and Consultation | 6 | 2018 | 3600 | 0.420 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 41 | 0.410 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 829 | 0.410 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 842 | 0.410 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 409 | 0.400 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1069 | 0.390 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1027 | 0.390 |
Why?
|
Natriuretic Peptides | 2 | 2011 | 155 | 0.380 |
Why?
|
Middle Aged | 52 | 2024 | 220921 | 0.380 |
Why?
|
Dietary Supplements | 5 | 2022 | 3415 | 0.350 |
Why?
|
Serum Albumin | 2 | 2024 | 672 | 0.350 |
Why?
|
Thyroid Hormones | 1 | 2013 | 404 | 0.340 |
Why?
|
Bone Density Conservation Agents | 4 | 2022 | 795 | 0.340 |
Why?
|
Osteoporosis | 4 | 2020 | 1606 | 0.340 |
Why?
|
Kidney Transplantation | 4 | 2019 | 4235 | 0.330 |
Why?
|
Vitamin D Deficiency | 3 | 2015 | 1388 | 0.330 |
Why?
|
Male | 60 | 2024 | 360846 | 0.320 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2009 | 65 | 0.320 |
Why?
|
Rare Diseases | 1 | 2014 | 622 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2014 | 3246 | 0.310 |
Why?
|
Warfarin | 5 | 2023 | 1483 | 0.310 |
Why?
|
Diuretics | 1 | 2011 | 610 | 0.310 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2008 | 163 | 0.310 |
Why?
|
Premedication | 1 | 2009 | 246 | 0.300 |
Why?
|
Female | 61 | 2024 | 392705 | 0.290 |
Why?
|
Acetylcysteine | 1 | 2009 | 260 | 0.290 |
Why?
|
Aged | 40 | 2024 | 169310 | 0.290 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1935 | 0.280 |
Why?
|
Hydrothorax | 1 | 2006 | 18 | 0.270 |
Why?
|
Vitamin D | 4 | 2016 | 3303 | 0.270 |
Why?
|
Metabolic Diseases | 1 | 2013 | 683 | 0.270 |
Why?
|
Biopsy | 4 | 2020 | 6766 | 0.260 |
Why?
|
Risk Factors | 20 | 2024 | 74213 | 0.260 |
Why?
|
Atrial Fibrillation | 3 | 2018 | 5127 | 0.250 |
Why?
|
Gastric Bypass | 1 | 2014 | 818 | 0.250 |
Why?
|
Natural Language Processing | 1 | 2014 | 1163 | 0.250 |
Why?
|
Cause of Death | 7 | 2020 | 3683 | 0.250 |
Why?
|
Glomerular Filtration Rate | 8 | 2023 | 2178 | 0.250 |
Why?
|
Fibromuscular Dysplasia | 1 | 2005 | 55 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2008 | 292 | 0.240 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15502 | 0.240 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3808 | 0.230 |
Why?
|
Diphosphonates | 2 | 2019 | 635 | 0.230 |
Why?
|
Polycythemia Vera | 1 | 2006 | 161 | 0.230 |
Why?
|
Inservice Training | 1 | 2006 | 376 | 0.230 |
Why?
|
Renal Artery | 1 | 2005 | 351 | 0.220 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.220 |
Why?
|
Metronidazole | 1 | 2004 | 232 | 0.210 |
Why?
|
Length of Stay | 4 | 2013 | 6426 | 0.210 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1277 | 0.210 |
Why?
|
Pyridones | 2 | 2018 | 809 | 0.210 |
Why?
|
Muscle Cramp | 1 | 2022 | 34 | 0.210 |
Why?
|
Hypercalcemia | 2 | 2023 | 423 | 0.210 |
Why?
|
Rickets | 1 | 2023 | 70 | 0.210 |
Why?
|
Homocysteine | 2 | 2016 | 638 | 0.200 |
Why?
|
Hypophosphatemia | 1 | 2023 | 92 | 0.200 |
Why?
|
Bone Density | 3 | 2020 | 3551 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2018 | 1516 | 0.200 |
Why?
|
Fanconi Syndrome | 1 | 2022 | 34 | 0.200 |
Why?
|
Databases, Factual | 4 | 2018 | 7968 | 0.200 |
Why?
|
Postoperative Complications | 4 | 2014 | 15633 | 0.190 |
Why?
|
International Classification of Diseases | 2 | 2019 | 910 | 0.190 |
Why?
|
Hospitalization | 2 | 2021 | 10721 | 0.190 |
Why?
|
Case-Control Studies | 7 | 2021 | 22176 | 0.190 |
Why?
|
Wound Healing | 2 | 2015 | 2805 | 0.190 |
Why?
|
Carnitine | 1 | 2022 | 252 | 0.180 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 63 | 0.180 |
Why?
|
Venous Thrombosis | 3 | 2018 | 1303 | 0.180 |
Why?
|
Cohort Studies | 12 | 2024 | 41495 | 0.180 |
Why?
|
Adult | 28 | 2024 | 221210 | 0.180 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12973 | 0.170 |
Why?
|
Anticoagulants | 4 | 2019 | 4812 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 463 | 0.170 |
Why?
|
Physician's Role | 1 | 2007 | 917 | 0.170 |
Why?
|
Peritoneal Neoplasms | 1 | 2006 | 711 | 0.170 |
Why?
|
Smell | 1 | 2022 | 259 | 0.170 |
Why?
|
Malnutrition | 2 | 2017 | 645 | 0.170 |
Why?
|
Fatal Outcome | 2 | 2015 | 1835 | 0.170 |
Why?
|
Blood Substitutes | 1 | 2019 | 57 | 0.170 |
Why?
|
Abdominal Pain | 1 | 2006 | 1071 | 0.170 |
Why?
|
Retrospective Studies | 22 | 2024 | 80647 | 0.170 |
Why?
|
Carbon-Carbon Ligases | 1 | 2019 | 19 | 0.160 |
Why?
|
Internal Medicine | 1 | 2006 | 1051 | 0.160 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 231 | 0.160 |
Why?
|
Patient Care Planning | 1 | 2024 | 909 | 0.150 |
Why?
|
Vitamin K 1 | 1 | 2018 | 47 | 0.150 |
Why?
|
Prognosis | 9 | 2021 | 29629 | 0.150 |
Why?
|
Renal Replacement Therapy | 3 | 2010 | 282 | 0.150 |
Why?
|
Pyrazoles | 2 | 2018 | 2009 | 0.150 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 173 | 0.150 |
Why?
|
Hyperbaric Oxygenation | 1 | 2019 | 165 | 0.150 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2021 | 396 | 0.150 |
Why?
|
Teriparatide | 1 | 2019 | 227 | 0.140 |
Why?
|
Hydroxyurea | 1 | 2018 | 284 | 0.140 |
Why?
|
Alanine | 1 | 2020 | 609 | 0.140 |
Why?
|
Pancreatitis | 1 | 2004 | 1096 | 0.140 |
Why?
|
Theophylline | 1 | 2017 | 131 | 0.140 |
Why?
|
Bone and Bones | 2 | 2019 | 2568 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2022 | 1492 | 0.140 |
Why?
|
Professional Practice | 1 | 2019 | 313 | 0.140 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 159 | 0.140 |
Why?
|
General Practice | 1 | 2017 | 97 | 0.140 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 214 | 0.130 |
Why?
|
Fractures, Bone | 2 | 2021 | 2046 | 0.130 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1738 | 0.130 |
Why?
|
Apatites | 1 | 2015 | 19 | 0.130 |
Why?
|
Cholesterol | 5 | 2014 | 2905 | 0.130 |
Why?
|
Debridement | 1 | 2018 | 493 | 0.130 |
Why?
|
Thrombophilia | 1 | 2018 | 305 | 0.120 |
Why?
|
Triglycerides | 4 | 2014 | 2461 | 0.120 |
Why?
|
Histone Deacetylases | 1 | 2019 | 720 | 0.120 |
Why?
|
Vitamin B 6 | 1 | 2016 | 234 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.120 |
Why?
|
Necrosis | 1 | 2019 | 1611 | 0.120 |
Why?
|
Albuminuria | 1 | 2018 | 658 | 0.120 |
Why?
|
Recurrence | 2 | 2024 | 8466 | 0.120 |
Why?
|
Regenerative Medicine | 1 | 2018 | 306 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1201 | 0.120 |
Why?
|
Massachusetts | 4 | 2020 | 8833 | 0.120 |
Why?
|
Signal Transduction | 1 | 2017 | 23447 | 0.120 |
Why?
|
Electrolytes | 1 | 2015 | 274 | 0.120 |
Why?
|
Risk Assessment | 9 | 2021 | 23996 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1479 | 0.110 |
Why?
|
Crohn Disease | 1 | 2006 | 2279 | 0.110 |
Why?
|
Calcium | 2 | 2018 | 5722 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58984 | 0.110 |
Why?
|
Time Factors | 9 | 2019 | 39969 | 0.110 |
Why?
|
Microvessels | 1 | 2018 | 577 | 0.110 |
Why?
|
Algorithms | 1 | 2014 | 14033 | 0.110 |
Why?
|
Leg | 1 | 2019 | 1088 | 0.110 |
Why?
|
Prevalence | 4 | 2024 | 15733 | 0.110 |
Why?
|
Spectrum Analysis, Raman | 1 | 2015 | 237 | 0.110 |
Why?
|
Chronic Disease | 5 | 2019 | 9319 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2023 | 992 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1509 | 0.110 |
Why?
|
Vitamin B 12 | 1 | 2016 | 524 | 0.110 |
Why?
|
Self Care | 1 | 2018 | 796 | 0.110 |
Why?
|
Nutritional Status | 2 | 2019 | 1615 | 0.100 |
Why?
|
Parathyroid Hormone | 2 | 2017 | 1803 | 0.100 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1972 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2022 | 1171 | 0.100 |
Why?
|
Comorbidity | 6 | 2020 | 10508 | 0.100 |
Why?
|
Fenoldopam | 1 | 2011 | 6 | 0.100 |
Why?
|
Diuretics, Osmotic | 1 | 2011 | 33 | 0.100 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2011 | 78 | 0.100 |
Why?
|
Minerals | 1 | 2013 | 283 | 0.100 |
Why?
|
Calcifediol | 1 | 2012 | 161 | 0.090 |
Why?
|
Medication Adherence | 2 | 2020 | 2176 | 0.090 |
Why?
|
Primary Health Care | 2 | 2007 | 4687 | 0.090 |
Why?
|
Age of Onset | 1 | 2018 | 3306 | 0.090 |
Why?
|
Perioperative Care | 2 | 2009 | 1036 | 0.090 |
Why?
|
Remission Induction | 2 | 2013 | 2397 | 0.090 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2011 | 152 | 0.090 |
Why?
|
Hypertension | 2 | 2022 | 8540 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 867 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2017 | 5293 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2006 | 4420 | 0.080 |
Why?
|
Treatment Outcome | 12 | 2019 | 64685 | 0.080 |
Why?
|
Proteinuria | 2 | 2009 | 607 | 0.080 |
Why?
|
Incidence | 3 | 2018 | 21355 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6345 | 0.080 |
Why?
|
Protein S Deficiency | 1 | 2008 | 13 | 0.080 |
Why?
|
Protein C Deficiency | 1 | 2008 | 25 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2986 | 0.080 |
Why?
|
Shock, Septic | 1 | 2015 | 768 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2013 | 771 | 0.080 |
Why?
|
Acute Disease | 2 | 2009 | 7237 | 0.080 |
Why?
|
Kidney | 3 | 2022 | 7048 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2319 | 0.080 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 973 | 0.070 |
Why?
|
Odds Ratio | 3 | 2009 | 9647 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15266 | 0.070 |
Why?
|
New York | 2 | 2007 | 874 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2012 | 553 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20100 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3415 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1761 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8321 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3578 | 0.070 |
Why?
|
Internship and Residency | 1 | 2006 | 5882 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2009 | 431 | 0.070 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2008 | 156 | 0.070 |
Why?
|
Splenomegaly | 1 | 2006 | 189 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 350 | 0.060 |
Why?
|
Survival Analysis | 3 | 2021 | 10090 | 0.060 |
Why?
|
Catheters, Indwelling | 1 | 2007 | 426 | 0.060 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2004 | 28 | 0.060 |
Why?
|
Connective Tissue Diseases | 1 | 2008 | 285 | 0.060 |
Why?
|
United States | 5 | 2021 | 72340 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2942 | 0.060 |
Why?
|
Disease Progression | 5 | 2023 | 13510 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
Registries | 2 | 2018 | 8225 | 0.060 |
Why?
|
Prospective Studies | 6 | 2024 | 54423 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5841 | 0.060 |
Why?
|
Aldosterone | 1 | 2009 | 870 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.060 |
Why?
|
Thoracic Surgery | 1 | 2010 | 722 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2019 | 3407 | 0.060 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2759 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 823 | 0.050 |
Why?
|
Palliative Care | 1 | 2018 | 3598 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Respiration, Artificial | 2 | 2018 | 2630 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2007 | 380 | 0.050 |
Why?
|
Portal Vein | 1 | 2006 | 431 | 0.050 |
Why?
|
Creatinine | 1 | 2009 | 1899 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8527 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.050 |
Why?
|
Vaginosis, Bacterial | 1 | 2004 | 151 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8481 | 0.050 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2009 | 1039 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2643 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4853 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 798 | 0.050 |
Why?
|
Radiography, Abdominal | 1 | 2005 | 534 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2009 | 868 | 0.050 |
Why?
|
China | 2 | 2018 | 2374 | 0.050 |
Why?
|
Calcitriol | 1 | 2023 | 296 | 0.050 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2021 | 65 | 0.050 |
Why?
|
Primary Prevention | 1 | 2009 | 1186 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 292 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4347 | 0.050 |
Why?
|
Age Factors | 3 | 2018 | 18399 | 0.050 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 76 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2016 | 11461 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14665 | 0.040 |
Why?
|
India | 1 | 2006 | 2348 | 0.040 |
Why?
|
Liver Transplantation | 2 | 2024 | 2330 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1595 | 0.040 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 2 | 2009 | 27 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 113 | 0.040 |
Why?
|
Phosphates | 1 | 2023 | 770 | 0.040 |
Why?
|
Penis | 1 | 2020 | 212 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1881 | 0.040 |
Why?
|
Administration, Oral | 2 | 2018 | 4021 | 0.040 |
Why?
|
Rats | 1 | 2015 | 23741 | 0.040 |
Why?
|
Neoplasms | 3 | 2022 | 22173 | 0.040 |
Why?
|
Animals | 4 | 2019 | 168475 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2022 | 699 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12463 | 0.040 |
Why?
|
Hip | 1 | 2019 | 255 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12723 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2018 | 66 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1379 | 0.040 |
Why?
|
Femur Neck | 1 | 2019 | 314 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17904 | 0.040 |
Why?
|
Health Resources | 1 | 2024 | 935 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9758 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 573 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4195 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1265 | 0.040 |
Why?
|
Hypolipidemic Agents | 2 | 2014 | 609 | 0.040 |
Why?
|
Injections | 1 | 2020 | 831 | 0.040 |
Why?
|
Quality of Life | 1 | 2018 | 13367 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2022 | 1170 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 290 | 0.030 |
Why?
|
Hyperkalemia | 2 | 2009 | 233 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3688 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 244 | 0.030 |
Why?
|
Hemorrhage | 2 | 2018 | 3424 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2018 | 292 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 471 | 0.030 |
Why?
|
Sodium Chloride, Dietary | 1 | 2018 | 293 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2019 | 581 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2018 | 500 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1718 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18255 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 679 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 467 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8633 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2009 | 3964 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 654 | 0.030 |
Why?
|
Radiography | 1 | 2006 | 6965 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1039 | 0.030 |
Why?
|
Patient Discharge | 1 | 2007 | 3443 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26129 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5079 | 0.030 |
Why?
|
Osteoporotic Fractures | 1 | 2019 | 411 | 0.030 |
Why?
|
Sepsis | 1 | 2008 | 2585 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10554 | 0.030 |
Why?
|
Curriculum | 1 | 2006 | 3743 | 0.030 |
Why?
|
Adolescent | 4 | 2018 | 88326 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12947 | 0.030 |
Why?
|
Upper Extremity | 1 | 2018 | 658 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1626 | 0.030 |
Why?
|
Spine | 1 | 2019 | 1118 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2013 | 280 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2018 | 794 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3124 | 0.020 |
Why?
|
Cost of Illness | 1 | 2022 | 1937 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2725 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14608 | 0.020 |
Why?
|
New England | 1 | 2015 | 1054 | 0.020 |
Why?
|
Aorta | 1 | 2019 | 2041 | 0.020 |
Why?
|
Abdomen | 1 | 2018 | 1128 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1085 | 0.020 |
Why?
|
Critical Illness | 1 | 2024 | 2723 | 0.020 |
Why?
|
Clinical Competence | 1 | 2006 | 4793 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 993 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4920 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3206 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15843 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1202 | 0.020 |
Why?
|
Dopamine Agents | 1 | 2010 | 189 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2024 | 0.020 |
Why?
|
Saline Solution, Hypertonic | 1 | 2009 | 114 | 0.020 |
Why?
|
Graft Rejection | 2 | 2014 | 4446 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10766 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3060 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2548 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2010 | 973 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9327 | 0.020 |
Why?
|
Inflammation | 2 | 2017 | 10774 | 0.010 |
Why?
|
Renin-Angiotensin System | 1 | 2009 | 737 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14417 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39106 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11076 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4016 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12149 | 0.010 |
Why?
|
Heart Failure | 1 | 2007 | 11671 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4811 | 0.010 |
Why?
|
Child | 2 | 2023 | 80158 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2011 | 1376 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2009 | 1474 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16592 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22174 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59260 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12341 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12690 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6312 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6345 | 0.010 |
Why?
|
Heart Diseases | 1 | 2010 | 2781 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36193 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42232 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12059 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81539 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27121 | 0.000 |
Why?
|